Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III. [electronic resource]

By: Contributor(s): Producer: 20170705Description: 575-585 p. digitalISSN:
  • 1365-2796
Subject(s): Online resources: In: Journal of internal medicine vol. 281
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.